Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (FDA) for its Pithampur Unit-1 ...

The Food and Drug Administration has given Lupin a tentative nod for two new generics. The first medication is loteprednol etabonate ophthalmic gel, 0.38%, which is a generic of Bausch & Lomb’s ...

Pharma sector grew 8% in FY24: Report The product will be manufactured at Lupin’s Pithampur facility in India. Prednisolone Acetate Ophthalmic Suspension USP, 1% is indicated for the treatment ...

of Janssen Pharmaceuticals, Inc. This product will be manufactured at Lupin’s Pithampur facility in India. USFDA gives nod to Lupin’s generic formulation to treat high uric acid Rivaroxaban ...

Lupin Ltd., a global pharmaceutical company, announced on December 30, the acquisition of the Huminsulin range of products in India from Eli Lilly and Company. The financial terms of the deal were ...

The Indian pharmaceutical industry will likely grow ... thus delivering higher operating leverage benefits. • Lupin: Motilal Oswal said Lupin has shown earnings turnaround, driven by the ...

Lupin: Pharmaceutical company Lupin received an Establishment Inspection Report (EIR) from the US FDA for its Pithampur Unit-1 facility, which manufactures APIs and finished products. The EIR ...